Neurocrine Bio. (NBIX) PT Lowered to $107 at Wedbush
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $165.11 +6.63%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $107.00 (from $112.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Meituan Dianping (3690:HK) (MPNGF) PT Lowered to HK$93 at Macquarie
- Old Dominion Freight Line (ODFL) PT Raised to $233 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
